Referensi Bab

7
Rakitis
Casey, C.F. dkk. “Vitamin D Supplementation in Infants, Children, and Adolescents”. Am
Fam Physician. 15 Mar 2010;81(6):745-8.
Chapman, T. dkk. “Fractures in Infants and Toddlers with Rickets”. Pediatr Radiol. 9 Des
2009.
Feldman D. dkk. 1997. Vitamin D. San Diego: Academic Press.
Greer, F.R. “Issues in Establishing Vitamin D Recommendations for Infants and
Children”. Am J Clin Nutr. Des 2004;80(6 Suppl):1759S-62S.
McKay, C.P. dan Portale A. “Emerging Topics in Pediatric Bone and Mineral Disorders
2008”. Semin Nephrol. Jul 2009;29(4):370-8.
Price, D.I. dkk. “Hypocalcemic Rickets: an Unusual Cause of Dilated
Cardiomyopathy”. Pediatr Cardiol. Sep-Okt 2003;24(5):510-2. 
Shah, B.R. dan Finberg L. “Single-day Therapy for Nutritional Vitamin D-Deficiency
Rickets: a Preferred Method”. J Pediatr. Sep 1994;125(3):487-90. 
Wagner, C.L. dan Greer F.R. “Prevention of Rickets and Vitamin D Deficiency in Infants,
Children, and Adolescents”. Pediatrics. Nov 2008;122(5):1142-52.
Zmora, E. dkk. “Multiple Nutritional Deficiencies in Infants from a Strict Vegetarian
Community”. Am J Dis Child. Feb 1979;133(2):141-4.

Osteomalasia
Bhambri, R. dkk. “Changes in Bone Mineral Density Following Treatment of
Osteomalacia.” J Clin Densitom. Jan–Mar 2006;9(1):120-7.
Hruska, K.A. dkk. “Renal Osteodystrophy, Phosphate Homeostasis, and Vascular
Calcification”. Semin Dial. Jul–Ag 2007;20(4):309-15.
Mankin, H.J. “Rickets, Osteomalacia, and Renal Osteodystrophy. An update”. Orthop Clin
North Am. Jan 1990;21(1):81-96.
Mankin, H.J. “Rickets, Osteomalacia, and Renal Osteodystrophy: Part I”. J Bone Joint
Surg [Am]. 1974;56:101-28.

R-51

Referensi.indb 51 12/7/2015 9:49:16 AM

 R-52 Buku Ajar Gangguan Muskuloskeletal

Mankin, H.J. dan Mankin C.J. “Metabolic Bone Disease: An Update”. Instr Course

Lect. 2003;52:769-84.
Murphey, M.D. dkk. “Musculoskeletal Manifestations of Chronic Renal Insufficiency”. 
Radiographics. Mar 1993;13(2):357-79.
Pitt, M.J. “Rickets and Osteomalacia Are Still Around”. Radiol Clin North
Am. Jan 1991;29(1):97-118.
Pugh, D.G. “Subperiosteal Resorption of Bone; A Roentgenologic Manifestation
of Primary Hyperparathyroidism and Renal Osteodystrophy”. AJR Am J
Roentgenol. 1951;66:577-86.
Reginato, A.J. dkk. “Musculoskeletal Manifestations of Osteomalacia: Report of 26 Cases
and Literature Review”. Semin Arthritis Rheum. Apr 1999;28(5):287-304.
Schwarz, C. dkk. “Diagnosis of Renal Osteodystrophy”. Eur J Clin Invest. Agust 2006;36
Suppl 2:13-22.
Steinbach, H.L. dkk. “A Mechanism of the Production of Pseudofractures in Osteomalacia
(Milkman’s Syndrome)”. Radiology. 1954;62:388-94.
Steinbach, H.L. dan Noetzli M. “Roentgen Appearance of the Skeleton in Osteomalacia
and Rickets’. AJR Am J Roentgenol. 1964;91:955.

Osteoporosis
Agency for Healthcare Research and Quality. “Fracture Prevention Treatments for
Postmenopausal Women with Osteoporosis. AHRQ: Agency for Healthcare
Research and Quality”.  http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=s
g&DocID=95&ProcessID=8,  30 Januari 2009.
Chon, K.S. dkk. “Alcoholism-Associated Spinal and Femoral Bone Loss in Abstinent
Male Alcoholics, as Measured by Dual X-ray Absorptiometry”. Skeletal
Radiol. 1992;21(7):431-6.
Czerwiski E. dkk. “Current Understanding of Osteoporosis According to the Position
of The World Health Organization (WHO) and International Osteoporosis
Foundation”. Ortop Traumatol Rehabil. Jul–Agust 2007;9(4):337-56. Review.
Iwamoto, J. dkk. “Effect of Exercise Training and Detraining on Bone Mineral Density in
Postmenopausal Women with Osteoporosis”. J Orthop Sci. 2001;6(2):128-32.
Kanis, J.A. “Assessment of Fracture Risk and Its Application to Screening for
Postmenopausal Osteoporosis: Synopsis of A WHO Report”. WHO Study
Group. Osteoporos Int. Nov 1994;4(6):368-81.
Kanis, J.A. dkk. “A Reference Standard for the Description of Osteoporosis”. Bone. Mar 
2008;42(3):467-75. Epub 2007 Nov 17.
Lau, E.M. dan Cooper C. “The Epidemiology of Osteoporosis. The Oriental Perspective
in A World Context”. Clin Orthop. Feb 1996;(323):65-74.
Lin, J.T. dan Lane J.M. “Nonmedical Management of Osteoporosis”. Curr Opin Rheum
atol. Jul 2002;14(4):441-6.

Referensi.indb 52 12/7/2015 9:49:16 AM

 Referensi R-53

Lynn, S.G. dkk. “Balance Characteristics of Persons with Osteoporosis”. Arch Phys Med

Rehabil. Mar 1997;78(3):273-7.
Osteoporos Int. “Who Are Candidates for Prevention and Treatment for
Osteoporosis?”. Osteoporos Int. 1997;7(1):1-6.
Schwab P. dan Klein R.F. “Nonpharmacological Approaches to Improve Bone Health and
Reduce Osteoporosis”. Curr Opin Rheumatol. Mar 2008;20(2):213-217.
Silverman, S.L. “Selecting Patients for Osteoporosis Therapy”. Ann N Y Acad
Sci. Nov 2007;1117:264-72.
Sinaki, M. dkk. “Correlation of Back Extensor Strength with Thoracic Kyphosis and
Lumbar Lordosis in Estrogen-Deficient Women”. Am J Phys Med Rehabil. Sep-
Okt 1996;75(5):370-4.
Snow, C.M. dkk. “Long-Term Exercise Using Weighted Vests Prevents Hip Bone Loss in
Postmenopausal Women”. J Gerontol A Biol Sci Med Sci. Sep 2000;55(9):M489-91.
Wolf S.L. dkk. “Reducing Frailty and Falls in Older Persons: an Investigation of
Tai Chi and Computerized Balance Training. Atlanta FICSIT Group. Frailty
and Injuries: Cooperative Studies of Intervention Techniques”. J Am Geriatr
Soc. Mei 1996;44(5):489-97.

Penyakit Paget
Alexandersen P. dkk. “Non-Isomerized C-Telopeptide Fragments are Highly Sensitive
Markers for Monitoring Disease Activity and Treatment Efficacy in Paget’s Disease
of Bone”. J Bone Miner Res. Apr 2005;20(4):588-95.
Alvarez, L. dkk. “Discriminative Value of Biochemical Markers of Bone Turnover in
Assessing the Activity of Paget’s Disease”. J Bone Miner Res. Mar 1995;10(3):458-
65. 
Ankrom, M.A. dan Shapiro J.R. “Paget’s Disease of Bone (osteitis deformans)”. J Am
Geriatr Soc. Agust 1998;46(8):1025-33.
Delmas, P.D. dan Meunier P.J. “The Management of Paget’s Disease of Bone”. N Engl J
Med. 20 Feb 1997;336(8):558-66.
Hadjipavlou, A.G. dkk. “Paget’s Disease of the Spine and Its Management”. Eur Spine
J. Okt 2001;10(5):370-84.
Harrington, K.D. “Surgical Management of Neoplastic Complications of Paget’s
Disease”. J Bone Miner Res. Okt 1999;14 Suppl 2:45-8.
Holgado, S. dkk. “Paget’s Disease of Bone in Early Adult Life”. Ann Rheum
Dis. Feb 2005;64(2):306-8.
Hughes, A.E. dkk. “Genetic Linkage of Familial Expansile Osteolysis to Chromosome
18q”. Hum Mol Genet. Feb 1994;3(2):359-61.
Kaplan, F.S. “Surgical Management of Paget’s Disease”. J Bone Miner Res. Okt 1999;14
Suppl 2:34-8.

Referensi.indb 53 12/7/2015 9:49:16 AM

 R-54 Buku Ajar Gangguan Muskuloskeletal

Kaplan, F.S. dan Singer F.R. “Paget’s Disease of Bone: Pathophysiology, Diagnosis, and
Management”. J Am Acad Orthop Surg. Nov 1995;3(6):336-344.
Leach, R.J. dkk. “Variable Disease Severity Associated with A Paget’s Disease Predisposition
Gene”. J Bone Miner Res. Okt 1999;14 Suppl 2:17-20.
Leach, R.J. dkk. “The Genetics of Paget’s Disease of the Bone”. J Clin Endocrinol
Metab. Jan 2001;86(1):24-8.
Menaa, C. dkk. “1,25-Dihydroxyvitamin D3 Hypersensitivity of Osteoclast Precursors
from Patients with Paget’s Disease”. J Bone Miner Res. Feb 2000;15(2):228-36.
Neale, S.D. dkk. “The Influence of Serum Cytokines and Growth Factors on Osteoclast
Formation in Paget’s Disease”. QJM. Apr 2002;95(4):233-40.
Noor, M. dan Shoback D. “Paget’s Disease of Bone: Diagnosis and Treatment Update”. Curr
Rheumatol Rep. Feb 2000;2(1):67-73.
Ooi, C.G. dan Fraser W.D. “Paget’s Disease of Bone”. Postgrad Med J. Feb 1997;73(856):69-
74.
Reddy, S.V. dkk. “Paget’s Disease of Bone: A Disease of the Osteoclast”. Rev Endocr Metab
Disord. Apr 2001;2(2):195-201.
Schneider, D. dkk. “Diagnosis and Treatment of Paget’s Disease of Bone”. Am Fam
Physician. 15 Mei 2002;65(10):2069-72.

Pseudohypoparathyroidism
Balavoine, A.S. dkk. “Hypothyroidism in Patients with Pseudohypoparathyroidism Type
Ia: Clinical Evidence of Resistance to TSH and TRH”. Eur J Endocrinol. Okt 200
8;159(4):431-7.
Bastepe, M. “The GNAS Locus and Pseudohypoparathyroidism”. Adv Exp Med
Biol. 2008;626:27-40.
Freson, K. dkk. “GNAS Defects Identified by Stimulatory G Protein Alpha-Subunit
Signalling Studies in Platelets”. J Clin Endocrinol Metab. Des 2008;93(12):4851-9.
Jan de Beur, S.M. dkk. “Pseudohypoparathyroidism 1b: Exclusion of Parathyroid Hormone
and Its Receptors as Candidate Disease Genes”. J Clin Endocrinol Metab. Jun 2000
;85(6):2239-46.
Juppner, H. dkk. “The Gene Responsible for Pseudohypoparathyroidism Type Ib
is Paternally Imprinted and Maps in Four Unrelated Kindreds to Chromosome
20q13.3”. Proc Natl Acad Sci U S A. 29 Sep 1998;95(20):11798-803.
Long, D.N. dkk. “Body Mass Index Differences in Pseudohypoparathyroidism Type 1a
Versus Pseudopseudohypoparathyroidism May Implicate Paternal Imprinting of
Galpha(s) in the Development of Human Obesity”. J Clin Endocrinol Metab. Mar 
2007;92(3):1073-9.
Mahmud, F.H. dkk. “Molecular Diagnosis of Pseudohypoparathyroidism Type Ib in A
Family with Presumed Paroxysmal Dyskinesia”. Pediatrics. Feb 2005;115(2):e242-4.

Referensi.indb 54 12/7/2015 9:49:17 AM

 Referensi R-55

Mantovani, G. dkk. “Growth Hormone-Releasing Hormone Resistance in

Pseudohypoparathyroidism Type 1a: New Evidence for Imprinting of the Gs Alpha
Gene”. J Clin Endocrinol Metab. Sep 2003;88(9):4070-4.
Murray, T.M. dkk. “Pseudohypoparathyroidism with Osteitis Fibrosa Cystica: Direct
Demonstration of Skeletal Responsiveness to Parathyroid Hormone in Cells Cultured
from Bone”. J Bone Miner Res. Jan 1993;8(1):83-91.
Nakamura Y. dkk. “Prevalence of Idiopathic Hypoparathyroidism and
Pseudohypoparathyroidism in Japan”. J Epidemiol. Jan 2000;10(1):29-33.
Root, A.W. dkk. 1996. “Parathyroid and Vitamin D-Related Disorders in Children and
Adolescents”.  Pediatric Endocrinology. Philadelphia, Pa: WB Saunders Company.
Shalitin, S. dkk. “Clinical Heterogeneity of pseudohypoparathyroidism: from Hyper-to
Hypocalcemia”. Horm Res. 2008;70(3):137-44.
Vlaeminck-Guillem, V. dkk. “Pseudohypoparathyroidism Ia and Hypercalcitoninemia”. J
Clin Endocrinol Metab. Jul 2001;86(7):3091-6.
Wagar, G. dkk. “Pseudohypoparathyroidism Associated with Hypercalcitoninaemia”. Acta
Endocrinol (Copenh). Jan 1980;93(1):43-8.
Yamamoto, Y. dkk. “Spinal Cord Compression by Heterotopic Ossification Associated
with Pseudohypoparathyroidism”. J Int Med Res. Nov–Des 1997;25(6):364-8. 

Hiperparatiroidisme
Ahmad, R. dan Hammond J.M. “Primary, Secondary, and Tertiary
Hyperparathyroidism”. Otolaryngol Clin North Am. Agust 2004;37(4):701-13, vii-viii.
Baumann, D.S. dan Wells S.A.Jr. “Parathyroid Autotransplantation”. Surgery. Feb 1993;
113(2):130-3.
Bilezikian, J.P. dan Silverberg, S.J. “Clinical Practice. Asymptomatic Primary
Hyperparathyroidism”. N Engl J Med. 22 Apr 2004;350(17):1746-51.
Bilezikian, J.P. dkk. “Primary Hyperparathyroidism: New Concepts in Clinical,
Densitometric and Biochemical Features”. J Intern Med. Jan 2005;257(1):6-17.
Boggs, J.E. dkk. “Intraoperative Parathyroid Hormone Monitoring as an Adjunct to
Parathyroidectomy”. Surgery. Des 1996;120(6):954-8.
Brown, E.M. “The Pathophysiology of Primary Hyperparathyroidism”. J Bone Miner
Res. Nov 2002;17 Suppl 2:N24-9.
Burney, R.E. dkk. “Surgical Correction of Primary Hyperparathyroidism Improves Quality
of Life”. Surgery. Des 1998;124(6):987-91; discussion 991-2.
Farford, B. dkk. “Nonsurgical Management of Primary Hyperparathyroidism”. Mayo Clin
Proc. Mar 2007;82(3):351-5.
Felsenfeld, A.J. “Considerations for the Treatment of Secondary Hyperparathyroidism in
Renal Failure”. J Am Soc Nephrol. Jun 1997;8(6):993-1004.
Greene, A.B. dkk. “National Trends in Parathyroid Surgery from 1998 to 2008: A Decade
of Change”. J Am Coll Surg. Sep 2009;209(3):332-43.

Referensi.indb 55 12/7/2015 9:49:17 AM

 R-56 Buku Ajar Gangguan Muskuloskeletal

Moley, J.F. dkk. “Hereditary Endocrinopathies”. Curr Probl Surg. Sep 1999;36(9):653-

762.
National Institutes of Health Consensus Development Conference Panel. NIH Conference.
“Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism:
Consensus Development Conference Statement”. Ann Intern Med. 1 Apr
1991;114(7):593-7.
Silverberg, S.J. dan Bilezikian J.P. “The Diagnosis and Management of Asymptomatic
Primary Hyperparathyroidism”. Nat Clin Pract Endocrinol Metab. Sep 2006;2(9):494-
503.
Silverberg, S.J. dkk. “Therapeutic Controversies in Primary Hyperparathyroidism”. J Clin
Endocrinol Metab. Jul 1999;84(7):2275-85.
Wells, S.A.Jr. dkk. “Transplantation of the Parathyroid Glands in Man: Clinical Indications
and Results”. Surgery. Jul 1975;78(1):34-44.

Avascular Necrosis
Aldridge, J.M.3rd. dan Urbaniak J.R. “Avascular Necrosis of the Femoral Head: Etiology,
Pathophysiology, Classification, and Current Treatment Guidelines”. Am J Orthop. Ju
l 2004;33(7):327-32.
Aldridge, J.M.3rd. dan Urbaniak J.R. “Avascular Necrosis of the Femoral Head: Role of
Vascularized Bone grafts. Orthop Clin North Am. Jan 2007;38(1):13-22,v.
Allen, M.R. dan Burr D.B. “The Pathogenesis of Bisphosphonate-Related Osteonecrosis of
The Jaw: So Many Hypotheses, so Few Data”. J Oral Maxillofac Surg. Mei 2009;67(5
Suppl):61-70.
Boettcher, W.G. dkk. “Non-Traumatic Necrosis of The Femoral Head. I. Relation of
Altered Hemostasis to Etiology”. J Bone Joint Surg Am. Mar 1970;52(2):312-21.
Calandriello, B. dan Grassi G. “Idiopathic Osteonecrosis of the Femoral Head. Epidemiological
and Aetiological Factors”. Ital J Orthop Traumatol. 1982;8 (Suppl):9-18.
Dudkiewicz, I. dkk. “Total Hip Arthroplasty After Avascular Necrosis of the Femoral Head:
Does Etiology Affect the Results?”. Arch Orthop Trauma Surg. Mar 2004;124(2):82-5.
Goker, B. dan Block J.A. “Risk of Contralateral Avascular Necrosis (AVN) After Total Hip
Arthroplasty (THA) for Non-Traumatic AVN”. Rheumatol Int. Jan 2006;26(3):215-9.
Imhof, H. dkk. “Imaging of Avascular Necrosis of Bone”. Eur Radiol. 1997;7(2):180-6.
Ito, H. dkk. “Prognosis of Early Stage Avascular Necrosis of the Femoral Head”. Clin
Orthop Relat Res. Jan 1999;149-57.
Kawai, K. dkk. “Steroid-Induced Accumulation of Lipid in the Osteocytes of the Rabbit
Femoral Head. A Histochemical and Electron Microscopic Study’. J Bone Joint Surg
Am. Jun 1985;67(5):755-63.
Lawson-Ayayi, S. dkk. “Avascular Necrosis in HIV-Infected Patients: A Case-Control
Study from The Aquitaine Cohort, 1997–2002, France”. Clin Infect Dis. 15 Apr
2005;40(8):1188-93.

Referensi.indb 56 12/7/2015 9:49:17 AM

 Referensi R-57

Mankin, H.J. “Nontraumatic Necrosis of Bone (Osteonecrosis)”. N Engl J Med. 28 Mei

1992;326(22):1473-9.
Pilmore, H. dkk. “Acute Bone Pain Following Renal Transplantation: Differentiation Between
Benign Bone Edema and Avascular Necrosis”. Am J Nephrol. 1998;18(1):57-60.
Pritchett, J.W. “Statin Therapy Decreases the Risk of Osteonecrosis in Patients Receiving
Steroids”. Clin Orthop. Mei 2001;(386):173-8.
Sugano, N. dkk. “Rotational Osteotomy for Non-Traumatic Avascular Necrosis of the
Femoral Head”. J Bone Joint Surg Br. Sep 1992;74(5):734-9.
Urbaniak, J.R. dkk. “Treatment of Osteonecrosis of the Femoral Head with Free
Vascularized Fibular Grafting. A Long-Term Follow-Up Study of One Hundred
and Three Hips”. J Bone Joint Surg Am. Mei 1995;77(5):681-94.
Van Laere, C. dkk. “Core Decompression for Avascular Necrosis of the Femoral Head”. Acta
Orthop Belg. Sep 1998;64(3):269-72.
Wang, G.J. dkk. “Steroid-Induced Femoral Head Pressure Changes and Their Response
to Lipid-Clearing Agents”. Clin Orthop Relat Res. Apr 1983;298-302.
Woo, S.B. dkk. “Narrative [corrected] Review: Bisphosphonates and Osteonecrosis of the
Jaws”. Ann Intern Med. 16 Mei 2006;144(10):753-61.
Zizic, T.M. dkk. “Corticosteroid Therapy Associated with Ischemic Necrosis of Bone in
Systemic Lupus Erythematosus”. Am J Med. Nov 1985;79(5):596-604.

Hypertrophic Osteoarthropathy
Angel-Moreno, Maroto A. dkk. “Painful Hypertrophic Osteoarthropathy Successfully
Treated with Octreotide. The Pathogenetic Role of Vascular Endothelial Growth
Factor (VEGF)”. Rheumatology (Oxford). Okt 2005;44(10):1326-7.
Atkinson, S. dan Fox S.B. “Vascular Endothelial Growth Factor (VEGF)-A and Platelet-
Derived Growth Factor (PDGF) Play a Central Role in the Pathogenesis of Digital
Clubbing”. J Pathol. Jun 2004;203(2):721-8.
Bigler, F.C. “The Morphology of Clubbing”. Am J Pathol. Mar–Apr 1958;34(2):237-61.
Branwood, A.W. “Clubbing of the Fingers”. Edinburgh Med J. Mar 1949;56(3):105-20.
Cameron, B.J. dkk. “Idiopathic Periosteal Hyperostosis with Dysproteinemia (Goldbloom’s
Syndrome): Case Report and Review of the Literature”. Arthritis Rheum. Nov 1987;
30(11):1307-12.
Hashmi, S. dan Kaplan D. “Asymmetric Clubbing as a Manifestation of Sarcoid Bone
Disease”. Am J Med. Okt 1992;93(4):471.
Martinez-Lavin, M. dkk. “Hypertrophic Osteoarthropathy: Consensus on Its Definition,
Classification, Assessment and Diagnostic Criteria”. J Rheumatol. Agust 1993;20(8):
1386-7.
Martinez-Lavin, M. dkk. “Primary Hypertrophic Osteoarthropathy”. Semin Arthritis
Rheum. Feb 1988;17(3):156-62.

Referensi.indb 57 12/7/2015 9:49:17 AM

 R-58 Buku Ajar Gangguan Muskuloskeletal

Martinez-Lavin, M. “Digital Clubbing and Hypertrophic Osteoarthropathy: A Unifying

Hypothesis”. J Rheumatol. Feb 1987;14(1):6-8.
Pichler, G. dkk. “Arthralgia and Digital Clubbing in a Child: Hypertrophic Osteoarthropathy
with Inflammatory Pseudotumour of the Lung”. Scand J Rheumatol. 2004;33(3):189-
91.
Pineda, C.J. dkk. “The Skeletal Manifestations of Clubbing: A Study in Patients with
Cyanotic Congenital Heart Disease and Hypertrophic Osteoarthropathy”. Semin
Arthritis Rheum. Mei 1985;14(4):263-73.
Reginato, A.J. dkk. “Familial Idiopathic Hypertrophic Osteoarthropathy and Cranial
Suture Defects in Children”. Skeletal Radiol. 1982;8(2):105-9.
Rothschild, B.M. dan Rothschild C. “Recognition of Hypertrophic Osteoarthropathy in
Skeletal Remains”. J Rheumatol. Nov 1998;25(11):2221-7.
Seaton, D.R. “Familial Clubbing of Fingers and Toes”. Br Med J. 1938;1:614.
Seggewiss R. dkk. “A Family with A Variant Form of Primary Hypertrophic Osteoarthropathy
Restricted to the Lower Extremities”. Joint Bone Spine. Jun 2003;70(3):230-3.
Sridhar, K.S. dkk. “Digital Clubbing and Lung Cancer”. Chest. Des 1998;114(6):1535-7.
Vazquez-Abad, D. dkk. “Digital Clubbing: A Numerical Assessment of the Deformity”. J
Rheumatol. Apr 1989;16(4):518-20.
Vidal, A.F. dkk. “Structural and Immunologic Changes of Synovium of Hypertrophic
Osteoarthropathy”. Arthritis Rheum. 1977;20:139.

Artritis gout
Akahoshi, T. dkk. “Recent Advances in Crystal-Induced Acute Inflammation”. Curr Opin
Rheumatol. Mar 2007;19(2):146-50.
Choi, H.K. dan Curhan G. “Soft Drinks, Fructose Consumption, and the Risk of Gout
in Men: Prospective Cohort Study. BMJ. 9 Feb 2008;336(7639):309-12.
Choi, H.K. dkk. “Alcohol Intake and Risk of Incident Gout in Men: A Prospective
Study”. Lancet. 17 Apr 2004;363(9417):1277-81.
Fam, A.G. dkk. “Efficacy and Safety of Desensitization to Allopurinol Following
Cutaneous Reactions”. Arthritis Rheum. Jan 2001;44(1):231-8.
Feig, D.I. dan Johnson R.J. “The Role of Uric Acid in Pediatric Hypertension”. J Ren
Nutr. Jan/2007;17(1):79-83.
Huang, H.Y. dkk. “The Effects of Vitamin C Supplementation on Serum Concentrations
of Uric Acid: Results of a Randomized Controlled Trial”. Arthritis Rheum. Jun 
2005;52(6):1843-7.
Lioté, F. dan Ea H.K. “Recent Developments in Crystal-Induced Inflammation
Pathogenesis and Management. Curr Rheumatol Rep. Jun 2007;9(3):243-50.
Puig, J.G. dkk. “Female Gout. Clinical Spectrum and Uric Acid Metabolism”. Arch Intern
Med. Apr 1991;151(4):726-32.

Referensi.indb 58 12/7/2015 9:49:17 AM

 Referensi R-59

Terkeltaub, R.A. dkk. “Apolipoprotein (apo) E Inhibits the Capacity of Monosodium

Urate Crystals to Stimulate Neutrophils. Characterization of Intraarticular Apo E
and Demonstration of Apo E Binding to Urate Crystals in Vivo. J Clin Invest. Jan 
1991;87(1):20-6.
US Food and Drug Administration. “FDA Takes Action to Stop the Marketing of
Unapproved Injectable Drugs Containing Colchicine”. www.fda.gov/bbs/topics/
news/2008/new01791.html, 30 September 2008.
Vázquez-Mellado, J. dkk. “Relation between Adverse Events Associated with Allopurinol and
Renal Function in Patients with Gout”. Ann Rheum Dis. Okt 2001;60(10):981-3.
Wallace, S.L. dkk. “Renal Function Predicts Colchicine Toxicity: Guidelines for the
Prophylactic Use of Colchicine in Gout”. J Rheumatol. Feb 1991;18(2):264-9.
Yu, T. “The Efficacy of Colchicine Prophylaxis in Articular Gout--A Reappraisal after 20
Years”. Semin Arthritis Rheum. Nov 1982;12(2):256-64.
Zhang, W. dkk. “EULAR Evidence Based Recommendations for Gout. Part II:
Management. Report of A Task Force of The EULAR Standing Committee for
International Clinical Studies Including Therapeutics (ESCISIT)”. Ann Rheum
Dis. Okt 2006;65(10):1312-24.

Calcium Pyrophosphate Deposition Disease

Beutler, A. dkk. “Calcium Pyrophosphate Dihydrate Crystal Deposition in Synovium.
Relationship to Collagen Fibers and Chondrometaplasia”. Arthritis Rheum. Mei 1
993;36(5):704-15.
Doherty, M. dkk. “Familial Chondrocalcinosis due to Calcium Pyrophosphate Dihydrate
Crystal Deposition in English Families”. Br J Rheumatol. Feb 1991;30(1):10-5.
Doherty, M. “Calcium Pyrophosphate Deposition Disease and Other Crystal Deposition
Diseases”. Curr Opin Rheumatol. Okt 1990;2(5):789-96.
Ea, H.K. dan Liote F. “Calcium Pyrophosphate Dihydrate and Basic Calcium Phosphate
Crystal-Induced Arthropathies: Update on Pathogenesis, Clinical Features, and
Therapy”. Curr Rheumatol Rep. Jun 2004;6(3):221-7.
Pritzker, K.P. dkk. “Calcium Pyrophosphate Crystal Deposition in Hyaline
Cartilage. Ultrastructural Analysis and Implications for Pathogenesis”. J
Rheumatol. 1988;15(5):828-35.
Pritzker, K.P. “Calcium Pyrophosphate Dihydrate Crystal Deposition and Other Crystal
Deposition Diseases”. Curr Opin Rheumatol. Jul 1994;6(4):442-7.
Rothschild, B.M. dan Woods R.J. “Osteoarthritis, Calcium Pyrophosphate Deposition
Disease, and Osseous infection in Old World Primates”. Am J Phys Anthropol. Mar
 1992;87(3):341-7.
Ryan, L.M. dkk. “Pyrophosphohydrolase Activity and Inorganic Pyrophosphate Content
of Cultured Human Skin Fibroblasts. Elevated Levels in Some Patients with Calcium
Pyrophosphate Dihydrate Deposition Disease”. J Clin Invest. Mei 1986;77(5):1689-93.

Referensi.indb 59 12/7/2015 9:49:17 AM

 R-60 Buku Ajar Gangguan Muskuloskeletal

Ryan, L.M. dkk. “Synovial Fluid ATP: A Potential Substrate for the Production of
Inorganic Pyrophosphate. J Rheumatol. Mei 1991;18(5):716-20.
Saffar, P. “Chondrocalcinosis of the Wrist”. J Hand Surg [Br]. Okt 2004;29(5):486-93.
Zaka, R. dan Williams, C.J. “Genetics of Chondrocalcinosis”. Osteoarthritis Cartilage. Sep
 2005;13(9):745-50.

Referensi.indb 60 12/7/2015 9:49:17 AM